Compare MNSB & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNSB | MBOT |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.8M | 135.7M |
| IPO Year | N/A | N/A |
| Metric | MNSB | MBOT |
|---|---|---|
| Price | $20.53 | $1.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 33.3K | ★ 1.1M |
| Earning Date | 01-27-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,367,000.00 | N/A |
| Revenue This Year | $21.22 | N/A |
| Revenue Next Year | $3.33 | $3,119.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.71 | N/A |
| 52 Week Low | $15.00 | $1.25 |
| 52 Week High | $22.98 | $4.67 |
| Indicator | MNSB | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 39.34 |
| Support Level | $19.77 | $1.96 |
| Resistance Level | $21.45 | $2.21 |
| Average True Range (ATR) | 0.58 | 0.10 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 56.28 | 5.66 |
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.